Download video

3.3K views

2 months ago

Managing Toxicities of TKIs and HIF-2 inhibitor in Renal Cell Carcinoma (RCC)
18:48
Managing Toxicities of TKIs and HIF-2 inhibitor in Renal Cell Carcinoma (RCC)
by OncBrothers: Practice-Changing Cancer Discussions
Teen beats rare cancer
1:57
Teen beats rare cancer
by FOX 32 Chicago
Teen utilizes fertility preservation program during cancer treatment
4:57
Teen utilizes fertility preservation program during cancer treatment
by WRTV Indianapolis
TK2d Day 2025 1080p
6:43
TK2d Day 2025 1080p
by International Mito Patients
HER2-Positive Gastric Cancer: DESTINY Trials, T-DXd vs Trastuzumab
9:18
HER2-Positive Gastric Cancer: DESTINY Trials, T-DXd vs Trastuzumab
by Edusurg Clinics
The future of enfortumab vedotin in triple-negative and HR+\/HER2- breast cancer
0:33
The future of enfortumab vedotin in triple-negative and HR+\/HER2- breast cancer
by VJOncology
HER2 Positive Breast Cancer: What You Need to Know
8:52
HER2 Positive Breast Cancer: What You Need to Know
by Cancer Treatment Updates
Selpercatinib and Pralsetinib for RET Fusions - 2025 Targeted Therapies in Lung Cancer Patient Forum
2:40
Selpercatinib and Pralsetinib for RET Fusions - 2025 Targeted Therapies in Lung Cancer Patient Forum
by Global Resource for Advancing Cancer Education
Clinical Trials for Pancreatic Cancer
21:15
Clinical Trials for Pancreatic Cancer
by Let's Win Pancreatic Cancer
Defining the Future Role of TROP2-Directed Antibody-Drug Conjugates in Non-Small Cell Lung Cancer
17:45
Defining the Future Role of TROP2-Directed Antibody-Drug Conjugates in Non-Small Cell Lung Cancer
by Research To Practice
Interview: UB researchers working on major breakthrough in treating pancreatic cancer
5:39
Interview: UB researchers working on major breakthrough in treating pancreatic cancer
by WIVBTV
Thriving after surviving cancer; the impact of cancer rehab on adolescents and young adults
2:27
Thriving after surviving cancer; the impact of cancer rehab on adolescents and young adults
by Select Medical
Intratumoral Vitamin C - Part 2
17:44
Intratumoral Vitamin C - Part 2
by Williams Cancer Institute
Case #2: Treating a Patient with Stage IV NSCLC with EGFR - 2025 Case Based Panel Discussions
31:07
Case #2: Treating a Patient with Stage IV NSCLC with EGFR - 2025 Case Based Panel Discussions
by Global Resource for Advancing Cancer Education
Cancer Prevention in Adolescence: How Do We Make a Difference? - M. Gilkey - 20250312
51:10
Cancer Prevention in Adolescence: How Do We Make a Difference? - M. Gilkey - 20250312
by UNC Lineberger Cancer Network
32 month follow-up of MOUNTAINEER: tucatinib and trastuzumab in HER2+ mCRC
1:11
32 month follow-up of MOUNTAINEER: tucatinib and trastuzumab in HER2+ mCRC
by VJOncology